Drug Shortage Report for ACT PREGABALIN
Report ID | 10981 |
Drug Identification Number | 02402920 |
Brand name | ACT PREGABALIN |
Common or Proper name | PREGABALIN |
Company Name | ACTAVIS PHARMA COMPANY |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | PREGABALIN |
Strength(s) | 50MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | N03AX |
ATC description | ANTIEPILEPTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2017-05-17 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2017-10-10 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2017-10-10 | French | Compare |
v5 | 2017-10-10 | English | Compare |
v4 | 2017-09-19 | French | Compare |
v3 | 2017-09-19 | English | Compare |
v2 | 2017-05-24 | French | Compare |
v1 | 2017-05-24 | English | Compare |
Showing 1 to 6 of 6